Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 12, 2022
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trialPaulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, et al.
JAMA Oncology|December 27, 2019
Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced CancerBrian C Baumann, Nandita Mitra, Joanna G Harton, et al.
International Journal of Cancer|February 5, 2020
Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotypeTong Xu, Hong-Tao Li, Jenny Wei, et al.
European Journal of Heart Failure|July 18, 2024
Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: A 36-week analysis from FOREST-HCMAhmad Masri, Roberto Barriales-Villa, Perry Elliott, et al.
Journal of Medical Economics|March 17, 2023
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving <i>reldesemtiv</i> or placebo in FORTITUDE-ALSPaulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, et al.
The American Journal of Hospice & Palliative Care|December 19, 2023
What Matters Most: The Documented Goals, Values and Motivators of Advanced Cancer PatientsAshley Aller, Aida Shirazi, Leon Pedell, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
The Journal of Clinical Investigation|November 10, 2022
Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndromeShreya Bhattacharya, Sayon Basu, Emily Sheng, et al.
JCO Oncology Practice|May 30, 2026
Optimizing Cancer Care Delivery Through High-Functioning Teams: Results of Implementing the 4R Oncology Model in Lung and Breast CancersJulia R Trosman, Christine B Weldon, Elizabeth Linehan, et al.
Circulation. Heart Failure|December 5, 2025
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCMJuan Pablo Kaski, Paul F Kantor, Stephanie J Nakano, et al.
Pageof 7